Total Payments
$21,507
2024 Payments
$193.98
Companies
12
Transactions
46
Medicare Patients
358
Medicare Billing
$35,687
Payment Breakdown by Category
Consulting$13,410 (62.4%)
Other$4,600 (21.4%)
Travel$1,886 (8.8%)
Food & Beverage$1,581 (7.4%)
Education$30.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $13,410 | 4 | 62.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,600 | 1 | 21.4% |
| Travel and Lodging | $1,886 | 9 | 8.8% |
| Food and Beverage | $1,581 | 30 | 7.4% |
| Education | $30.00 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dova Pharmaceuticals | $11,308 | 5 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $5,237 | 10 | $0 (2024) |
| Incyte Corporation | $4,021 | 11 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $173.77 | 11 | $0 (2021) |
| Seattle Genetics, Inc. | $148.50 | 1 | $0 (2017) |
| CSL Behring | $145.00 | 2 | $0 (2024) |
| Agios Pharmaceuticals, Inc. | $140.00 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $125.00 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2020) |
| Bioverativ Therapeutics Inc. | $52.55 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $193.98 | 5 | CSL Behring ($145.00) |
| 2021 | $4,629 | 3 | Dova Pharmaceuticals ($4,600) |
| 2020 | $2,625 | 2 | Dova Pharmaceuticals ($2,500) |
| 2019 | $8,418 | 18 | Dova Pharmaceuticals ($4,208) |
| 2018 | $43.54 | 3 | Novartis Pharmaceuticals Corporation ($31.69) |
| 2017 | $5,598 | 15 | Alexion Pharmaceuticals, Inc. ($5,207) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | CSL Behring | — | Food and Beverage | In-kind items and services | $85.00 | General |
| 12/06/2024 | CSL Behring | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 09/05/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $15.00 | General |
| Category: Rare Disease | ||||||
| 08/06/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Oncology | ||||||
| 08/06/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $15.00 | General |
| Category: Rare Disease | ||||||
| 11/19/2021 | Dova Pharmaceuticals | Doptelet (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,600.00 | General |
| Category: Hematology/Oncology | ||||||
| 05/11/2021 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: ONCOLOGY | ||||||
| 04/26/2021 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), RYDAPT | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2020 | Dova Pharmaceuticals | Doptelet (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Hematology/Oncology | ||||||
| 03/05/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 12/08/2019 | Agios Pharmaceuticals, Inc. | TIBSOVO (Drug) | Food and Beverage | In-kind items and services | $140.00 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2019 | Dova Pharmaceuticals | Doptelet (Drug) | Food and Beverage | In-kind items and services | $95.41 | General |
| Category: Hepatology | ||||||
| 10/15/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: ONCOLOGY | ||||||
| 09/27/2019 | Incyte Corporation | — | Travel and Lodging | Cash or cash equivalent | $54.56 | General |
| 09/27/2019 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| 09/27/2019 | Incyte Corporation | — | Travel and Lodging | Cash or cash equivalent | $45.43 | General |
| 09/27/2019 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $12.84 | General |
| 09/27/2019 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $6.48 | General |
| 09/14/2019 | Dova Pharmaceuticals | Doptelet (Drug) | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| Category: Hepatology | ||||||
| 09/14/2019 | Dova Pharmaceuticals | Doptelet (Drug) | Travel and Lodging | Cash or cash equivalent | $112.15 | General |
| Category: Hepatology | ||||||
| 03/28/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: ONCOLOGY | ||||||
| 03/25/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: ONCOLOGY | ||||||
| 02/17/2019 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: ONCOLOGY | ||||||
| 01/31/2019 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $3,300.00 | General |
| 01/11/2019 | Incyte Corporation | — | Travel and Lodging | Cash or cash equivalent | $289.65 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 116 | 143 | $71,628 | $10,520 |
| 2022 | 3 | 62 | 82 | $52,378 | $7,794 |
| 2021 | 3 | 51 | 74 | $33,865 | $5,914 |
| 2020 | 7 | 129 | 156 | $76,642 | $11,458 |
Total Patients
358
Total Services
455
Medicare Billing
$35,687
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 35 | 50 | $25,250 | $4,102 | 16.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 28 | 37 | $14,800 | $2,209 | 14.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $18,718 | $2,093 | 11.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 13 | 13 | $6,770 | $1,070 | 15.8% |
| 99448 | Telephone or internet assessment with verbal and written report by consulting physician, 21-30 minutes | Facility | 2023 | 12 | 13 | $3,965 | $662.35 | 16.7% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2023 | 15 | 17 | $2,125 | $383.52 | 18.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $23,038 | $2,950 | 12.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 20 | 28 | $14,140 | $2,452 | 17.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 26 | 38 | $15,200 | $2,392 | 15.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 16 | 27 | $13,455 | $2,366 | 17.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 19 | 23 | $10,810 | $2,037 | 18.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 16 | 24 | $9,600 | $1,512 | 15.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 22 | 22 | $31,677 | $4,149 | 13.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 29 | 37 | $14,890 | $2,781 | 18.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 12 | 21 | $9,345 | $1,378 | 14.7% |
| 99449 | Telephone or internet assessment and management service provided by consultative physician, 31 minutes or more of medical consultative discussion and review | Facility | 2020 | 16 | 16 | $7,440 | $1,047 | 14.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 15 | 23 | $7,900 | $869.68 | 11.0% |
| 99448 | Telephone or internet assessment and management service provided by consultative physician with verbal and written report, 21-30 minutes of medical consultative discussion and review | Facility | 2020 | 13 | 13 | $2,860 | $675.61 | 23.6% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2020 | 22 | 24 | $2,530 | $558.77 | 22.1% |
About Dr. Ellen Friedman, MD
Dr. Ellen Friedman, MD is a Hematology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215026539.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ellen Friedman, MD has received a total of $21,507 in payments from pharmaceutical and medical device companies, with $193.98 received in 2024. These payments were reported across 46 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($13,410).
As a Medicare-enrolled provider, Friedman has provided services to 358 Medicare beneficiaries, totaling 455 services with total Medicare billing of $35,687. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Location Bronx, NY
- Active Since 10/12/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1215026539
Products in Payments
- Doptelet (Drug) $11,308
- SOLIRIS (Drug) $5,207
- ADCETRIS (Biological) $148.50
- TIBSOVO (Drug) $140.00
- BRILINTA (Drug) $125.00
- JARDIANCE (Drug) $125.00
- KISQALI (Drug) $58.65
- VOTRIENT (Drug) $41.22
- PROMACTA (Drug) $35.62
- ULTOMIRIS (Biological) $30.00
- MEKINIST (Drug) $24.44
- CARVYKTI (Drug) $18.98
- JADENU (Drug) $13.84
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Bronx
Tauseef Ahmed, M.d, M.D
Hematology — Payments: $203,317
Hematology $203,317
Dr. Lucia Wolgast, M.d, M.D
Hematology — Payments: $23,003
Hematology $23,003
Henny Billett, Md, MD
Hematology — Payments: $12,556
Hematology $12,556
Zwi Schreiber, Md, MD
Hematology — Payments: $3,053
Hematology $3,053
Michael Stemerman, Md, MD
Hematology — Payments: $844.25
Hematology $844.25
Dr. Karenza Alexis, Md, MD
Hematology — Payments: $125.48
Hematology $125.48